Committee Composition

Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member
  Audit Compensation Nominating and Governance
Donnelly, Howard Chairman of the Board      
Clemmer, James C.      
Auen, Eileen   Member of Compensation Committee  
Gold, Jeffrey Member of Audit Committee   Member of Nominating and Governance Committee
Gould, Kevin   Committee Chair for Compensation Committee  
Johnson, Wesley Member of Audit Committee   Committee Chair for Nominating and Governance Committee
LaPorte, Steve   Member of Compensation Committee Member of Nominating and Governance Committee
Meteny, Dennis Committee Chair for Audit Committee    

Dennis S. Meteny joined the AngioDynamics Board of Directors in March 2004. Mr. Meteny is President and Chief Executive Officer of Cygnus Manufacturing Company LLC, a privately held manufacturer of minimally- and non-invasive medical device products; health and safety components; and high-precision transportation, aerospace and industrial products. From 2003-06, Mr. Meteny was an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, a strategic economic development initiative of the University of Pittsburgh Health System, Carnegie Mellon University, the University of Pittsburgh, the state of Pennsylvania and local foundations. From 2001-03 he was President and Chief Operating Officer of TissueInformatics Inc., a privately-held company engaged in the medical imaging business. From 2000-01, Mr. Meteny was a business consultant to various technology companies. Prior to that, Mr. Meteny spent 15 years in several executive-level positions, including as President and Chief Executive Officer from 1994-99, of Respironics Inc., a cardio-pulmonary medical device company. Mr. Meteny holds a B.S. in accounting from The Pennsylvania State University and an M.B.A. from the University of Pittsburgh.

Reed, Jan Member of Audit Committee    
  • Stock Information
  • Ticker ANGO
    Exchange NASDAQ
    Price $16.54
    Change - 0.07
    Volume 229,139
    Mar 23, 2018 - 4:00 PM ET
  • Search Investor Relations